IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $279,000 | -19.8% | 7,934 | +4.6% | 0.02% | -10.0% |
| Q2 2015 | $348,000 | +3.9% | 7,583 | +6.0% | 0.02% | 0.0% |
| Q1 2015 | $335,000 | +22.3% | 7,157 | -17.2% | 0.02% | +11.1% |
| Q4 2014 | $274,000 | +15.1% | 8,643 | -13.8% | 0.02% | +5.9% |
| Q3 2014 | $238,000 | +3.0% | 10,021 | +30.1% | 0.02% | 0.0% |
| Q2 2014 | $231,000 | +9.5% | 7,704 | -3.6% | 0.02% | +6.2% |
| Q1 2014 | $211,000 | -12.4% | 7,994 | -16.7% | 0.02% | -20.0% |
| Q4 2013 | $241,000 | +28.9% | 9,602 | +4.9% | 0.02% | +11.1% |
| Q3 2013 | $187,000 | +8.7% | 9,155 | +6.1% | 0.02% | 0.0% |
| Q2 2013 | $172,000 | – | 8,630 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |